skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

The effect of angiotensin receptor blockers on C-reactive protein and other circulating inflammatory indices in man

Review

(2233) Views  (642) Full article downloads

Authors: Alessandra Del Fiorentino, Silvana Cianchetti, Alessandro Celi, Giulia Dell’Omo, Roberto Pedrinelli

Published Date February 2009 Volume 2009:5 Pages 233 - 242
DOI: http://dx.doi.org/10.2147/VHRM.S4800

Alessandra Del Fiorentino, Silvana Cianchetti, Alessandro Celi, Giulia Dell’Omo, Roberto Pedrinelli

Dipartimento Cardio Toracico e Vascolare, Università di Pisa, Italy

Abstract: Anti-inflammatory properties may contribute to the pharmacological effects of angiotensin II receptor blockers (ARBs), a leading therapeutic class in the management of hypertension and related cardiovascular and renal diseases. That possibility, supported by consistent evidence from in-vitro and animal studies showing pro-inflammatory properties of angiotensin II, has been evaluated clinically by measuring the effect of ARBs on C-reactive protein and other circulating indices of inflammation (e-selectin, adhesion molecules, interleukin-6, tissue necrosis factor-alpha, monocyte chemoattractant protein-1) of potential clinical relevance, a body of evidence that this paper aims to review.

Keywords: renin–angiotensin system, angiotensin II type 1 receptor blockers, vascular inflammation, C-reactive protein, circulating inflammatory markers






 

Other articles by Professor Roberto Pedrinelli



Readers of this article also read:

Effect of angiotensin receptor blockade on endothelial function: focus on olmesartan medoxomil
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Cardiovascular disease in patients with chronic kidney disease
Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
Comparative assessment of angiotensin receptor blockers in different clinical settings
Health literacy and health seeking behavior among older men in a middle-income nation
Erratum
Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?
Lack of a relationship between circulating gamma-glutamyltransferase levels and carotid intima media thickness in hypertensive and diabetic patients
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University